Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression implicated in various cancers.
• Dysregulation of miRNAs, including acting as oncogenes or tumor suppressors, is common in human cancers.
• Thyroid papillary cancer (TPC) is a prevalent endocrine malignancy with complex molecular underpinnings.

Purpose of the Study:

• To investigate the role of miR-181b in the development and progression of human thyroid papillary cancer.
• To explore the functional impact of miR-181b downregulation on TPC cell behavior.
• To identify and validate the direct molecular targets of miR-181b in thyroid cancer cells.

Main Methods:

• Microarray analysis to compare miRNA expression in TPC tissues versus normal tissues.
• In vitro assays (MTT, colony formation, apoptosis) to assess the functional effects of miR-181b inhibition.
• Luciferase reporter assays, qPCR, and Western blot to validate miR-181b targets and downstream effects.

Main Results:

• miR-181b expression was significantly higher in thyroid papillary cancer tissues compared to adjacent normal tissues.
• Downregulation of miR-181b in TPC cells led to reduced cellular proliferation and induced apoptosis.
• Luciferase assays confirmed that CYLD is a direct target of miR-181b, with its protein expression upregulated upon miR-181b inhibition.

Conclusions:

• miR-181b promotes thyroid papillary cancer cell growth and inhibits apoptosis, at least partly by suppressing CYLD.
• Downregulation of miR-181b exhibits anti-cancer effects in thyroid papillary cancer.
• Targeting miR-181b represents a potential therapeutic strategy for human thyroid papillary cancer.